Get started
Author

See Wee Lim

ORCID: 0000-0002-3043-4577
Observed ORCID: 0000-0002-3043-4577
OpenAlex ID: A5073736391
DEAD-box helicase DP103 defines metastatic potential of human breast cancers
2014 · Eun Myoung Shin, Hui Sin Hay, et al. · Journal of Clinical Investigation · 132
PDF
Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma
2018 · Liang Xu, Ye Chen, et al. · Proceedings of the National Academy of Sciences · 111
A STAT3-based gene signature stratifies glioma patients for targeted therapy
2019 · Melanie Si Yan Tan, Edwin Sandanaraj, et al. · Nature Communications · 110
PDF
Epi-Detected Hyperspectral Stimulated Raman Scattering Microscopy for Label-Free Molecular Subtyping of Glioblastomas
2018 · Kideog Bae, Wei Zheng, et al. · Analytical Chemistry · 56
Multiplexed RNA profiling by regenerative catalysis enables blood-based subtyping of brain tumors
2023 · Yan Zhang, Chi Yan Wong, et al. · Nature Communications · 43
PDF
Topography of transcriptionally active chromatin in glioblastoma
2021 · Liang Xu, Ye Chen, et al. · Science Advances · 31
Integrative multi-omics approach to targeted therapy for glioblastoma
2022 · Lynnette Koh, Wisna Novera, et al. · Pharmacological Research · 26
EZH2 functional dichotomy in reactive oxygen species-stratified glioblastoma
2024 · Lynnette Wei Hsien Koh, Qing You Pang, et al. · Neuro-Oncology · 5
Glioportal: a comprehensive transcriptomic resource unveiling ligand-mediated mesenchymal transition in glioblastoma
2025 · Qing You Pang, Wisna Novera, et al. · Neuro-Oncology · 4
ETC-501 Is a Brain-Penetrant MNK Inhibitor That Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy
2026 · Giselle Sek Suan Nah, Yuk Kien Chong, et al. · Cancer Research · 2
Abstract 4726: ETC-501, a novel brain penetrant MNK kinase inhibitor, potentiates TMZ-induced senescence and sensitizes glioblastoma cells to senolytic therapy
2025 · Giselle Nah, Yuk Kien Chong, et al. · Cancer Research · 1
Data from ETC-501 Is a Brain-Penetrant MNK Inhibitor That Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy
2026 · Giselle Sek Suan Nah, Yuk Kien Chong, et al.
Figure S2 from ETC-501 Is a Brain-Penetrant MNK Inhibitor That Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy
2026 · Giselle Sek Suan Nah, Yuk Kien Chong, et al.
Figure S4 from ETC-501 Is a Brain-Penetrant MNK Inhibitor That Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy
2026 · Giselle Sek Suan Nah, Yuk Kien Chong, et al.
Figure S5 from ETC-501 Is a Brain-Penetrant MNK Inhibitor That Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy
2026 · Giselle Sek Suan Nah, Yuk Kien Chong, et al.
Figure S6 from ETC-501 Is a Brain-Penetrant MNK Inhibitor That Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy
2026 · Giselle Sek Suan Nah, Yuk Kien Chong, et al.
Figure S3 from ETC-501 Is a Brain-Penetrant MNK Inhibitor That Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy
2026 · Giselle Sek Suan Nah, Yuk Kien Chong, et al.
Supplementary Tables from ETC-501 Is a Brain-Penetrant MNK Inhibitor That Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy
2026 · Giselle Sek Suan Nah, Yuk Kien Chong, et al.
Figure S1 from ETC-501 Is a Brain-Penetrant MNK Inhibitor That Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy
2026 · Giselle Sek Suan Nah, Yuk Kien Chong, et al.
Abstract 2123: Chromatin profiling of glioblastoma tissues identifies core oncogenic dependency and therapeutic opportunities
2021 · Liang Xu, Ye Chen, et al. · Cancer Research
Works count: 20
Citation count: 521
H-index: 7
I10-index: 7
Year
Topic
Type